AIPPI Rapid Response Report: Debating Lyrica's recurring pain on plausibility, abuse and infringement By David Brophy on Thursday, December 08, 2016 abuse of process AIPPI UK seminar amendment lyrica plausibility Pregabalin Second medical use skinny label Warner-Lambert +
Young EPLAW Congress: Brexit, SPCs, Skinny Labels and SEPs washed down with ample amounts of Belgian beer By Annsley Merelle Ward on Tuesday, April 19, 2016 AmeriKat EPLAW European patent litigation groundless threats infringement. groundless threats Second medical use SEPs skinny label SPCs Young IP Lawyers +
Fordham 2016: Will purposive construction of Swiss-type claims save second-medical use patents? By Annsley Merelle Ward on Tuesday, April 05, 2016 AmeriKat cost of medicines EPC 2000 event report Fordham 2016 incentivization patent enforcement Second medical use skinny label Swiss claims +
Yet another pregabalin decision - application to amend struck out as abuse of process By Darren Smyth on Wednesday, November 25, 2015 abuse of process actavis infringement insufficiency inventive step limitation patent Second medical use skinny label strike out swiss form claim validity Warner-Lambert +
Vive la différence? No need for Pregabalin(e) injunction, say the French By Jeremy on Wednesday, November 11, 2015 france Jeremy Phillips patent infringement pregalabin preliminary injunction Second medical use skinny label +
When litigants must be responsible -- and what happens when they're not: Lyrica pregabalin injunction is continued By Jeremy on Monday, November 09, 2015 England and Wales full label generics infringement interim injunctive relief Jeremy Phillips Second medical use skinny label +
The Lyrica patent dispute – part the second - infringement By Darren Smyth on Friday, November 06, 2015 actavis infringement insufficiency inventive step patent Second medical use skinny label swiss form claim validity Warner-Lambert +